Spear Bio Inc. raised $45M in a Series A financing co-led by Foresite Capital and Bio-Techne Corporation to accelerate the launch of protein research and disease diagnostics products.
Spear Bio Inc. raised $45M in a Series A financing co-led by Foresite Capital and Bio-Techne Corporation to accelerate the launch of protein research and disease diagnostics products.
07/29/24, 11:11 AM
Location
woburnMoney raised
$45 million
Industry
biotechnology
Round Type
series a
Investors
Cdh Investments, Yonjin Capital, Maverick Ventures, Bio Techne Corporation, Foresite Capital
Spear Bio Inc. announced the successful closing of its $45 million Series A financing, aimed at advancing their innovative protein measurement technology. The round was oversubscribed and included participation from notable investors including Maverick Ventures and Yonjin Capital.
Company Info
Location
woburn, massachusetts, united states
Additional Info
Spear Bio – founded in 2021 and headquartered in Woburn, Massachusetts – is an innovative leader in providing scalable solutions for ultra-sensitive protein biomarker measurements. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar level from sub-microliter sample volume. Spear Bio is focused on leveraging its technology’s unprecedented sensitivity to transform protein research and early disease diagnosis.